#USA #GammaTile #Dartmouth #GT Medical Technologies #Dartmouth Cancer Center

GT Medical Technologies Recognizes Dartmouth Cancer Center

GT Medical Technologies, renowned for its commitment to improving the lives of patients suffering from brain tumors, has recently designated Dartmouth Cancer Center as a GammaTile® Center of Excellence. This prestigious title, announced on December 17, 2025, highlights the center's exceptional dedication to innovative patient care and advancements in brain tumor treatments.

Importance of the GammaTile® Center of Excellence

The GammaTile Center of Excellence program is designed to recognize institutions and medical professionals who demonstrate outstanding expertise and capabilities in delivering high-quality patient care through the GammaTile procedure. This special acknowledgment is reserved for physicians and hospitals that meet rigorous clinical criteria, maintain a minimum annual case volume, and commit to ongoing education within the field.

Dr. Linton Evans, Dr. Nathan Simmons, Dr. Greg Russo, Dr. Nupur Lala, and Dr. Tulika Ranjan are among the prominent physicians now recognized for their exceptional skills in neurosurgery and neuro-oncology. Their expertise will enable them to deliver optimal care in managing brain tumors using groundbreaking therapies.

Understanding GammaTile and Its Benefits

GammaTile is a revolutionary radiation therapy that integrates a bioabsorbable collagen implant embedded with radiation seeds, administered at the time of tumor removal surgery. Unlike conventional radiation treatments, which typically require intervals between surgery and therapy to ensure the healing of wounds, GammaTile allows for immediate, targeted radiation precisely at the tumor site. This technique is particularly advantageous, as it treats remaining cancer cells when their levels are at their lowest, thereby significantly reducing the risk of tumor recurrence.

The core benefit of GammaTile is its strategy for delivering localized radiation that minimizes exposure to healthy brain tissue while effectively addressing malignant cells. As a result, patients can achieve better outcomes without the complications of traditional dosage regimens.

GT Medical Technologies and its Vision

Established by a dedicated team of brain tumor specialists, GT Medical Technologies aims to tackle existing challenges in brain tumor treatment effectively. Since launching GammaTile in March 2020, the company has witnessed growing acceptance across more than 100 prominent centers, showcasing both academic institutions and community healthcare facilities that embrace this innovative technique.

The company remains committed to enhancing the standard of care for brain cancer patients through ongoing innovation and research. By collaborating with experts and institutions like Dartmouth Cancer Center, GT Medical Technologies is paving the way for improved patient outcomes and hope for those battling brain tumors.

For further details, visit gammatile.com and follow @GammaTile on popular social media platforms like Facebook, Instagram, LinkedIn, and X to stay updated on the latest developments.

Conclusion

The designation of Dartmouth Cancer Center as a GammaTile Center of Excellence is a significant step toward advancing the landscape of brain tumor treatment. Through innovative approaches and dedicated medical professionals, patients can expect enhanced care, reduced risks associated with treatment delays, and improved chances of recovery. This initiative underscores the importance of collaboration within the medical community to achieve the best possible outcomes for those affected by brain cancers.